Search Videos and More
The ALLSTAR Clinical Trial Explained
More than three years after a clinical trial was prematurely ended for failing to show progress in healing heart attack scars, a prominent peer-reviewed journal is publishing some surprising results showing that the heart cell treatment does benefit patients.Cardiac Side Effects Found in 2 COVID-19 Drugs
About 12% of nearly 100 patients hospitalized with COVID-19 (coronavirus) developed a cardiac abnormality after receiving hydroxychloroquine and azithromycin—two drugs currently being administered to some coronavirus patients worldwide—according to an uncontrolled study reported May 28 by Cedars-Sinai in the Journal of the American Heart Association.Bairey Merz, MD, Wins Pioneer in Medicine Award
Noel Bairey Merz, MD, has a stellar academic background, including degrees from the University of Chicago and Harvard Medical School. But she jokes that she got a crucial boost in her pioneering research into women's heart disease by learning from someone with a different sort of pedigree.Cardio-Oncology Gets to the Heart of Cancer Patients' Health
Cedars-Sinai experts in the Smidt Heart Institute are making heart health a priority for cancer survivors and patients through the Cardio-Oncology Program. The program is more relevant than ever because cancer patients are living longer than ever. The five-year relative survival rate for all cancers combined has increased substantially since the early 1960s, from 39% to 70% among white patients and from 27% to 64% among African American patients.